Cuál es el precio por Aarti Pharmalabs Limited (AARTIPHARM)

Precio por Aarti Pharmalabs Limited (AARTIPHARM) es de$9.28

Cuál es la capitalización de mercado por Aarti Pharmalabs Limited (AARTIPHARM)

Capitalización de mercado por Aarti Pharmalabs Limited (AARTIPHARM) es $841.31M

Aarti Pharmalabs Limited (AARTIPHARM) Ratio P/S

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Año	Ratio P/S	Cambiar
Not enough data for the provided dates.

Año

Ratio P/S

Cambiar

Not enough data for the provided dates.

Empresa	Ratio P/S	Diferencia del ratio P/S	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN

Empresa

Ratio P/S

Diferencia del ratio P/S

País